Is a complete RAPP research report available?

No complete published report is available for Rapport Therapeutics, Inc. (RAPP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Rapport Therapeutics, Inc. (RAPP)

NASDAQ: RAPP · USD

$22.5

-5.05 (-18.3%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	20M
Net income (ttm)	-137.2M
EPS (ttm)	-$3.05
Shares out	48M
Volume	5,606,655
Beta	1.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 20M
Net income (ttm): -137.2M
EPS (ttm): -$3.05
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0002012593
Company name	Rapport Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	75383L102
Earnings date	2026-11-09
Earnings time	bmo
Employees	84
Enterprise value	$653.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2022
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2024-06-07
Is primary listing	Yes
Is SPAC	No
ISIN number	US75383L1026
Last 10-K release date	2026-03-10
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.1B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$22.49
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	RAPP
U.S. state	Massachusetts
Website	https://www.rapportrx.com

Metric

Value

Amount currency

USD

CIK code

0002012593

Company name

Rapport Therapeutics, Inc.

Country

United States

Country code

CUSIP number

75383L102

Earnings date

2026-11-09

Earnings time

bmo

Employees

Enterprise value

$653.1M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2022

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2024-06-07

Is primary listing

Yes

Is SPAC

ISIN number

US75383L1026

Last 10-K release date

2026-03-10

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.1B

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$22.49

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

RAPP

U.S. state

Massachusetts

Website

https://www.rapportrx.com

Metric	Value
Earnings yield	-13.57%
EV/Sales	33.13x
FCF / EV yield	-14.66%
FCF yield	-8.92%
Forward EV/Sales	9,939.33x
Forward P/S	16,328.59x
P/B ratio	3.12x
P/S ratio	54.43x
Price / tangible book value	2.57x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-13.57%

EV/Sales

33.13x

FCF / EV yield

-14.66%

FCF yield

-8.92%

Forward EV/Sales

9,939.33x

Forward P/S

16,328.59x

P/B ratio

3.12x

P/S ratio

54.43x

Price / tangible book value

2.57x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	-109.39%
Operating margin	-767.58%
Pretax margin	-685.8%
Profit per employee	$-1.6M
Revenue per employee	$238,095
ROA	-25.78%
ROCE	-35.66%
ROE	-39.96%
ROIC	-27.09%
SBC / revenue	122.96%

Metric

Value

Gross margin

-109.39%

Operating margin

-767.58%

Pretax margin

-685.8%

Profit per employee

$-1.6M

Revenue per employee

$238,095

ROA

-25.78%

ROCE

-35.66%

ROE

-39.96%

ROIC

-27.09%

SBC / revenue

122.96%

Metric	Value
EPS growth years	2
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-467,000
Depreciation and amortization	$960,000
EBIT	$-153.5M
EBITDA	$-152.6M
EPS	$-3.05
FCF per share	$-2.02
Financing cash flow	$272.8M
Free cash flow	$-97.1M
Free cash flow minus SBC	$-121.7M
Gross profit	$-21.9M
Investing cash flow	$-167.6M
Net cash flow	$8.5M
Net income	$-137.2M
Operating cash flow minus SBC	$-121.3M
Operating income	$-153.5M
Revenue	$20M
Stock-based compensation	$24.6M

Metric

Value

Capital expenditures

$-467,000

Depreciation and amortization

$960,000

EBIT

$-153.5M

EBITDA

$-152.6M

EPS

$-3.05

FCF per share

$-2.02

Financing cash flow

$272.8M

Free cash flow

$-97.1M

Free cash flow minus SBC

$-121.7M

Gross profit

$-21.9M

Investing cash flow

$-167.6M

Net cash flow

$8.5M

Net income

$-137.2M

Operating cash flow minus SBC

$-121.3M

Operating income

$-153.5M

Revenue

$20M

Stock-based compensation

$24.6M

Metric	Value
Altman Z-Score	20.27
Book value per share	$8.82
Debt / equity	0.02
Long-term assets	$12.1M
Long-term liabilities	$7.6M
Net cash (debt)	$426M
Net cash / market cap	39.13%
Net cash growth	71.36%
Net debt / equity	-1.01
Piotroski F-Score	1
Property, plant and equipment	$11.1M
Shareholders' equity	$422.9M
Tangible book value	$422.9M
Tangible book value per share	$8.82
Total assets	$459M
Total cash	$436.1M
Total debt	$10.1M
Total liabilities	$36.1M
WACC	10.86%

Metric

Value

Altman Z-Score

20.27

Book value per share

$8.82

Debt / equity

0.02

Long-term assets

$12.1M

Long-term liabilities

$7.6M

Net cash (debt)

$426M

Net cash / market cap

39.13%

Net cash growth

71.36%

Net debt / equity

-1.01

Piotroski F-Score

Property, plant and equipment

$11.1M

Shareholders' equity

$422.9M

Tangible book value

$422.9M

Tangible book value per share

$8.82

Total assets

$459M

Total cash

$436.1M

Total debt

$10.1M

Total liabilities

$36.1M

WACC

10.86%

Metric	Value
Asset turnover	0.05
Current assets	$446.9M
Current liabilities	$28.4M
Current ratio	15.72
Net working capital	$-15.2M
Quick ratio	15.35
Working capital	$418.4M
Working capital turnover	0.06

Metric

Value

Asset turnover

0.05

Current assets

$446.9M

Current liabilities

$28.4M

Current ratio

15.72

Net working capital

$-15.2M

Quick ratio

15.35

Working capital

$418.4M

Working capital turnover

0.06

Metric	Value
Buyback yield / dilution	-27.52%
Dividend yield	0%
Shareholder yield	-27.52%

Metric

Value

Buyback yield / dilution

-27.52%

Dividend yield

Shareholder yield

-27.52%

Metric	Value
150-day SMA	$38.22
1D price change	-18.34%
1M price change	-34.27%
1M total return	-34.27%
1W price change	-24.11%
1W total return	-24.11%
1Y price change	-15.82%
1Y return CAGR	-15.83%
1Y total return	-15.82%
20-day SMA	$28.75
200-day SMA	$35.67
3M price change	-47.09%
3M total return	-47.09%
50-day SMA	$37.65
50-day SMA vs 200-day SMA	50over200
52-week high	$52.93
52-week high date	2026-08-27
52-week low	$22.10
52-week low date	2026-10-28
6M price change	-37.03%
6M total return	-37.03%
All-time high	$52.93
All-time high date	2026-08-27
All-time low	$6.43
All-time low date	2025-03-04
Average true range (ATR)	$2.71
Average volume	1.1M
Beta (1Y)	2.01
Beta (2Y)	1.68
Beta (5Y)	1.22
Change from 52-week high	-57.51%
Change from 52-week low	1.79%
Change from all-time high	-57.89%
Change from all-time low	246.66%
Change from open	-0.04%
Day's gap	-18.3%
Dollar volume	$126.1M
High price	$23.83
Low price	$22.10
Monthly RSI	44.39
Open price	$22.50
Position in 52-week range	22.54%
Premarket change	-18.3%
Premarket close	$27.54
Premarket price	$22.50
Premarket volume	373.2K
Previous close	$27.54
Price vs 150-day SMA	-41.67%
Price vs 20-day SMA	-22.46%
Price vs 200-day SMA	-37.52%
Price vs 50-day SMA	-40.8%
Relative volume	4.89
Return from IPO open	26.06%
Return from IPO price	33.47%
RSI	28.93
Sharpe ratio	-0.02
Sortino ratio	0.06
Volume	5.6M
Weekly RSI	28.95
YTD price change	-26.53%
YTD total return	-26.53%

Metric

Value

150-day SMA

$38.22

1D price change

-18.34%

1M price change

-34.27%

1M total return

-34.27%

1W price change

-24.11%

1W total return

-24.11%

1Y price change

-15.82%

1Y return CAGR

-15.83%

1Y total return

-15.82%

20-day SMA

$28.75

200-day SMA

$35.67

3M price change

-47.09%

3M total return

-47.09%

50-day SMA

$37.65

50-day SMA vs 200-day SMA

50over200

52-week high

$52.93

52-week high date

2026-08-27

52-week low

$22.10

52-week low date

2026-10-28

6M price change

-37.03%

6M total return

-37.03%

All-time high

$52.93

All-time high date

2026-08-27

All-time low

$6.43

All-time low date

2025-03-04

Average true range (ATR)

$2.71

Average volume

1.1M

Beta (1Y)

2.01

Beta (2Y)

1.68

Beta (5Y)

1.22

Change from 52-week high

-57.51%

Change from 52-week low

1.79%

Change from all-time high

-57.89%

Change from all-time low

246.66%

Change from open

-0.04%

Day's gap

-18.3%

Dollar volume

$126.1M

High price

$23.83

Low price

$22.10

Monthly RSI

44.39

Open price

$22.50

Position in 52-week range

22.54%

Premarket change

-18.3%

Premarket close

$27.54

Premarket price

$22.50

Premarket volume

373.2K

Previous close

$27.54

Price vs 150-day SMA

-41.67%

Price vs 20-day SMA

-22.46%

Price vs 200-day SMA

-37.52%

Price vs 50-day SMA

-40.8%

Relative volume

4.89

Return from IPO open

26.06%

Return from IPO price

33.47%

RSI

28.93

Sharpe ratio

-0.02

Sortino ratio

0.06

Volume

5.6M

Weekly RSI

28.95

YTD price change

-26.53%

YTD total return

-26.53%

Metric	Value
Float	32.3M
Float percentage	67.4%
Shares change (QoQ)	0.5%
Shares change (YoY)	27.52%
Shares held by insiders	4.18%
Shares held by institutions	79.52%
Shares outstanding	48M
Short % of float	9.44%
Short % of shares	6.36%
Short ratio	6.7 days

Metric

Value

Float

32.3M

Float percentage

67.4%

Shares change (QoQ)

0.5%

Shares change (YoY)

27.52%

Shares held by insiders

4.18%

Shares held by institutions

79.52%

Shares outstanding

48M

Short % of float

9.44%

Short % of shares

6.36%

Short ratio

6.7 days

Metric	Value
Page views	158

Metric

Value

Page views

158

Rapport Therapeutics, Inc. (RAPP)

Price

Financial snapshot

Fair-value bridge

Latest news · RAPP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RAPP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on RAPP

Frequently asked questions